SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-08-086583
Filing Date
2008-04-22
Accepted
2008-04-22 12:52:11
Documents
5
Effectiveness Date
2008-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS ddefa14a.htm DEFA14A 25528
2 GRAPHIC g98097img001.jpg GRAPHIC 110931
3 GRAPHIC g98097img002.jpg GRAPHIC 49881
4 GRAPHIC g98097img003.jpg GRAPHIC 30667
5 GRAPHIC g98097img004.jpg GRAPHIC 40197
  Complete submission text file 0001193125-08-086583.txt   346825
Mailing Address 20245 SW 95TH AVENUE TUALATIN OR 97062
Business Address 20245 SW 95TH AVENUE TUALATIN OR 97062 5036928001
BIOJECT MEDICAL TECHNOLOGIES INC (Filer) CIK: 0000810084 (see all company filings)

IRS No.: 931099680 | State of Incorp.: OR | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-15360 | Film No.: 08768753
SIC: 3841 Surgical & Medical Instruments & Apparatus